Rankings
▼
Calendar
VSTM Q4 2018 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$1M
90.4% margin
Operating Income
-$34M
-2831.3% margin
Net Income
-$11M
-937.9% margin
EPS (Diluted)
$-1.49
QoQ Revenue Growth
-92.2%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$41M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$277M
Total Liabilities
$153M
Stockholders' Equity
$124M
Cash & Equivalents
$130M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$0
—
Gross Profit
$1M
$0
—
Operating Income
-$34M
-$18M
-89.8%
Net Income
-$11M
-$18M
+37.8%
Revenue Segments
Product Revenue Reserves And Allowances Government Rebates And Other Incentives
$128,000
58%
Product Revenue Reserves And Allowances Third Party Payer Chargebacks Discounts And Fees
$48,000
22%
Product Revenue Reserves And Allowances Trade Discounts And Allowances
$42,000
19%
Product Revenue And Allowances Returns
$1,000
0%
← FY 2018
All Quarters
Q1 2019 →